Galen Partners Completes Sale of Cambrooke Therapeutics
STAMFORD, Conn., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused, growth equity investment firm, announced today the sale of Cambrooke Therapeutics, Inc. (“Cambrooke”) to Ajinomoto Co. Cambrooke is a global leader and innovator in …